futibatinib
otsuka
[]
p: unresectable/metastatic pretreatment intrahepatic cholangiocarcinoma ecog ps 0,1 i:futibitainib 20 mg po daily o: or 42%, duration of response 9.5 months, mpfs 8.9 month, mos 20 months toxicity: hyperphosphatemia, increased ast
#asco2022 #medtwitter #
No one fights alone